| Tachyarrhythmias |
| Clinical
features Investigations Therapy Prevention Prognosis |
Wolff-Parkinson-White syndrome
Terminate the rhythm using diltiazem 0.25 mg/kg
a
Why? Wolff-Parkinson-White syndrome: diltiazem is more effective than placebo at cardioversion
|
Expiry date:
July 2004
Levels of Evidence used in grading these guides
| Author | CM Ball |
| Reviewer | H Oral |
| CAT Writers | CM Ball , N Shenker , CJ Wotton |